Under the auspices of the International AIDS Society, an international working group of researchers developed and published a Global Scientific Strategy “Towards an HIV Cure”, which was launched at a scientific symposium immediately preceding the XIX International AIDS Conference in Washington, DC in July 2012. The symposium brought together over 300 researchers in basic, clinical and social sciences and community representatives and provided a platform to present state-of-the-art research on the HIV cure research priority areas defined in the strategy.
Following the successful launch of the Global Scientific Strategy “Towards an HIV Cure” in Washington, DC in July 2012, the IAS and the “Towards an HIV Cure” Advisory Board are organizing another 2-day scientific symposium on 29 & 30 June 2013, immediately prior to the 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Kuala Lumpur.
The symposium, co-chaired by Françoise Barré-Sinoussi, IAS President, and Steven Deeks, Professor of Medicine at the University of California, San Francisco (UCSF), will be closely linked to the IAS 2013 conference programme. The symposium will bring together senior, mid-career and junior scientists, clinical researchers, scientific journalists, research funding administrators and community representatives.
Registration for the 2013 Towards an HIV Cure symposium is now open, please apply here.
The IAS will invite submissions of abstracts pertinent to HIV cure research, and sessions will be organized at IAS 2013 to report on the highlights of the symposium. Relevant abstracts submitted to the IAS Conference can be considered for oral or poster presentation at the symposium, in particular those in the categories outlined below.
Please submit abstracts online at www.ias2013.org; abstract submission will be open from 1 December 2012 until 24 January 2013. Abstract submitters must indicate that they would like their abstract to be considered for the “Towards an HIV Cure” pre-conference symposium using the opt-in tick-box on the submission page.
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.
More information and Call for Abstracts, here: